Participants 61 101 6
patients with chronic active hepatitis C
Participants 240 283 7
85 patients with chronic active hepatitis C
Participants 339 425 6
55 patients who responded to interferon by normalization of alanine transaminase (ALT)
Participants 1093 1135 4
A second, independent group of 43 patients
